LONG-TERM EFFICACY AND SAFETY OF RAVULIZUMAB, A LONG-ACTING TERMINAL COMPLEMENT INHIBITOR, IN ADULTS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-POSITIVE GENERALIZED MYASTHENIA GRAVIS: RESULTS FROM THE PHASE 3 CHAMPION MG OPEN-LABEL EXTENSION
MUSCLE & NERVE（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要